News
AMTI
--
0.00%
--
Applied Molecular Therapeutics To Present At 3 Upcoming Events In Sept., Oct.: Sept. 22, Oct. 15, Oct. 19
Applied Molecular Transport Inc. (NASDAQ:AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that the company will participate in the following investor events in September and October. Details of
Benzinga · 09/17 12:10
Applied Molecular Transport Announces Upcoming Investor Events in September and October
SOUTH SAN FRANCISCO, Calif., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that the company will participate in the following investor events in Septemb...
GlobeNewswire · 09/17 12:00
We're Hopeful That Applied Molecular Transport (NASDAQ:AMTI) Will Use Its Cash Wisely
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Simply Wall St. · 09/15 10:34
BRIEF-Applied Molecular Transport Appoints Holly Schachner To Its Board Of Directors
reuters.com · 08/24 20:31
Applied Molecular Transport Appoints Holly Schachner, M.D. to its Board of Directors
SOUTH SAN FRANCISCO, Calif., Aug. 24, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced the appointment of Holly Schachner, M.D. a seasoned and accomplished industry ...
GlobeNewswire · 08/24 20:01
Founders Fund V Management, LLC Buys Applied Molecular Transport Inc, Porch Group Inc, Sells ...
GuruFocus News · 08/23 09:18
Applied Molecular Q2 EPS $(0.62) Up From $(1.11) YoY
Applied Molecular (NASDAQ:AMTI) reported quarterly losses of $(0.62) per share. This is a 44.14 percent increase over losses of $(1.11) per share from the same period last year.
Benzinga · 08/10 20:22
BRIEF-Applied Molecular Transport Reports Second Quarter 2021 Financial Results
reuters.com · 08/10 20:21
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Benzinga · 08/09 12:09
Applied Molecular Transport to Present at Canaccord Genuity's 41st Annual Growth Conference
Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during Canaccord Genuity's 41st Annual...
GlobeNewswire · 08/05 12:00
EPIQ Capital Group, LLC Buys Applied Molecular Transport Inc, Lucira Health Inc, AppLovin Corp, ...
GuruFocus News · 07/30 22:38
Pacific Heights Asset Management Llc Buys Affirm Holdings Inc, Applied Molecular Transport Inc, ...
GuruFocus News · 07/23 18:38
Burleson & Company, LLC Buys Enphase Energy Inc, Lordstown Motors Corp, The Home Depot Inc, ...
GuruFocus News · 07/22 18:38
Applied Molecular posts additional data from early-stage AMT-101 ulcerative colitis trial
Applied Molecular Transport (AMTI) announces additional Phase 1b data for oral AMT-101 in ulcerative colitis ((UC)) patients.The Phase 1b multiple ascending dose trial evaluated safety and was a randomized, placebo-controlled 3:1,
Seekingalpha · 07/09 12:30
Applied Molecular Transport Presents Additional Positive Data from Oral AMT-101 Phase 1b in Ulcerative Colitis at ECCO '21 Virtual Congress
Once daily, oral AMT-101 was safe and well tolerated, and demonstrated trends of improvement in objective measures of inflammation: fecal calprotectin, CRP, and histology
GlobeNewswire · 07/09 12:00
Applied Molecular Transport Reports Positive Additional Data From Phase 1b Trial of AMT-101 to Treat UC Patients
MT Newswires · 07/09 08:44
Applied Molecular Transport slumps 5% as director sells shares
Applied Molecular Transport ([[AMTI]] -4.8%) stock drops 4.5% as director Helen Susan Kim sells 200,000 shares.Shares were priced between $43.3 to $46.47, worth approximately $8.7M.Director holds 600,000 shares post transaction.The stock has
Seekingalpha · 07/07 17:24
BRIEF-Applied Molecular Transport Inc Files For Mixed Shelf Size Not Disclosed - SEC Filing
reuters.com · 07/01 10:37
31 Stocks Moving In Monday's Mid-Day Session
Gainers Lydall, Inc. (NYSE: LDL) shares climbed 82.3% to $60.68 after the company agreed to be acquired by Unifrax for $61.10 per share.
Benzinga · 06/21 16:00
Virpax Pharmaceuticals, Anavex Life Sciences leads healthcare gainers; Aptevo Therapeutics, Intec Pharma among major losers
Gainers: Virpax Pharmaceuticals (VRPX) +16%, Anavex Life Sciences AVXL +15%, MediciNova MNOV +14%, Aytu Biopharma (AYTU) +14%, Applied Molecular Transport (AMTI) +8%.Losers: Aptevo Therapeutics (APVO) -18%, Intec Pharma (NTEC) -16%, Conformis (CFMS) -14%, ...
Seekingalpha · 06/21 15:02
Webull provides a variety of real-time AMTI stock news. You can receive the latest news about Applied Molecular Transport Inc. through multiple platforms. This information may help you make smarter investment decisions.
About AMTI
Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company. The Company is leveraging its technology platform to design and develop a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The Company is building a portfolio of oral product candidates based on its technology platform including its product candidate, AMT-101, an oral GI-selective rhIL-10 that has completed a Phase 1b clinical trial in patients with ulcerative colitis (UC). The Company’s other product candidate, AMT-126, is a GI-selective oral fusion of rhIL-22. The Company’s technology platform enables it to design and develop various oral biologic therapeutic modalities, such as peptides, proteins, full-length antibodies, antibody fragments, and ribonucleic acid (RNA) therapeutics, with development-stage drugs.